List of Tables
Table 1. Influenza Drugs Market Trends
Table 2. Influenza Drugs Market Drivers & Opportunity
Table 3. Influenza Drugs Market Challenges
Table 4. Influenza Drugs Market Restraints
Table 5. Global Influenza Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Influenza Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Influenza Drugs Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Influenza Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Influenza Drugs Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Influenza Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Influenza Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Influenza Drugs
Table 13. Global Influenza Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Influenza Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Influenza Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Influenza Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Influenza Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Influenza Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Influenza Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Influenza Drugs Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Influenza Drugs Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Influenza Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Influenza Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Influenza Drugs Price by Type (2019-2024) & (USD/MT)
Table 27. Global Influenza Drugs Price by Type (2025-2030) & (USD/MT)
Table 28. Global Influenza Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Influenza Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Influenza Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Influenza Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Influenza Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Influenza Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Influenza Drugs Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Influenza Drugs Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Influenza Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Influenza Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Influenza Drugs Price by Application (2019-2024) & (USD/MT)
Table 39. Global Influenza Drugs Price by Application (2025-2030) & (USD/MT)
Table 40. Global Influenza Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Influenza Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Influenza Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Influenza Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Influenza Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Influenza Drugs Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Influenza Drugs Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Influenza Drugs Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Influenza Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Influenza Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Influenza Drugs Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Influenza Drugs Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Influenza Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Influenza Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Influenza Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Influenza Drugs Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Influenza Drugs Sales Volume, (2025-2030) & (K MT)
Table 57. Bristol-Myers Squibb] Company Information
Table 58. Bristol-Myers Squibb] Introduction and Business Overview
Table 59. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Bristol-Myers Squibb] Influenza Drugs Product Offerings
Table 61. Bristol-Myers Squibb] Recent Development
Table 62. AstraZeneca Company Information
Table 63. AstraZeneca Introduction and Business Overview
Table 64. AstraZeneca Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. AstraZeneca Influenza Drugs Product Offerings
Table 66. AstraZeneca Recent Development
Table 67. Eli Lilly Company Information
Table 68. Eli Lilly Introduction and Business Overview
Table 69. Eli Lilly Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Eli Lilly Influenza Drugs Product Offerings
Table 71. Eli Lilly Recent Development
Table 72. Roche Company Information
Table 73. Roche Introduction and Business Overview
Table 74. Roche Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. Roche Influenza Drugs Product Offerings
Table 76. Roche Recent Development
Table 77. GlaxoSmithKline Company Information
Table 78. GlaxoSmithKline Introduction and Business Overview
Table 79. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. GlaxoSmithKline Influenza Drugs Product Offerings
Table 81. GlaxoSmithKline Recent Development
Table 82. Novartis Company Information
Table 83. Novartis Introduction and Business Overview
Table 84. Novartis Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. Novartis Influenza Drugs Product Offerings
Table 86. Novartis Recent Development
Table 87. Pfizer Company Information
Table 88. Pfizer Introduction and Business Overview
Table 89. Pfizer Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. Pfizer Influenza Drugs Product Offerings
Table 91. Pfizer Recent Development
Table 92. Sanofi Pasteur Company Information
Table 93. Sanofi Pasteur Introduction and Business Overview
Table 94. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 95. Sanofi Pasteur Influenza Drugs Product Offerings
Table 96. Sanofi Pasteur Recent Development
Table 97. Bayer Company Information
Table 98. Bayer Introduction and Business Overview
Table 99. Bayer Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 100. Bayer Influenza Drugs Product Offerings
Table 101. Bayer Recent Development
Table 102. Celgene Company Information
Table 103. Celgene Introduction and Business Overview
Table 104. Celgene Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 105. Celgene Influenza Drugs Product Offerings
Table 106. Celgene Recent Development
Table 107. Seqirus Company Information
Table 108. Seqirus Introduction and Business Overview
Table 109. Seqirus Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. Seqirus Influenza Drugs Product Offerings
Table 111. Seqirus Recent Development
Table 112. Protein Sciences Corporation Company Information
Table 113. Protein Sciences Corporation Introduction and Business Overview
Table 114. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. Protein Sciences Corporation Influenza Drugs Product Offerings
Table 116. Protein Sciences Corporation Recent Development
Table 117. Serum Institute of India Company Information
Table 118. Serum Institute of India Introduction and Business Overview
Table 119. Serum Institute of India Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 120. Serum Institute of India Influenza Drugs Product Offerings
Table 121. Serum Institute of India Recent Development
Table 122. Emergent Biosolutions Company Information
Table 123. Emergent Biosolutions Introduction and Business Overview
Table 124. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 125. Emergent Biosolutions Influenza Drugs Product Offerings
Table 126. Emergent Biosolutions Recent Development
Table 127. BioCryst Pharmaceuticals Company Information
Table 128. BioCryst Pharmaceuticals Introduction and Business Overview
Table 129. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 130. BioCryst Pharmaceuticals Influenza Drugs Product Offerings
Table 131. BioCryst Pharmaceuticals Recent Development
Table 132. Alvogen Company Information
Table 133. Alvogen Introduction and Business Overview
Table 134. Alvogen Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 135. Alvogen Influenza Drugs Product Offerings
Table 136. Alvogen Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Influenza Drugs Downstream Customers
Table 140. Influenza Drugs Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs Product Picture
Figure 2. Global Influenza Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Influenza Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Influenza Drugs Sales Volume (2019-2030) & (K MT)
Figure 5. Global Influenza Drugs Sales Price (2019-2030) & (USD/MT)
Figure 6. Influenza Drugs Report Years Considered
Figure 7. Global Influenza Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Influenza Drugs Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Drugs Revenue in 2023
Figure 10. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Zanamivir Picture
Figure 12. Oseltamivir Phosphate Picture
Figure 13. Peramivir Picture
Figure 14. Other Influenza Drugs Picture
Figure 15. Global Influenza Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Influenza Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Influenza Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 18. Global Influenza Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Influenza Drugs Price by Type (2019-2030) & (USD/MT)
Figure 20. Product Picture of Adults
Figure 21. Product Picture of Chidren
Figure 22. Global Influenza Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Influenza Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Influenza Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 25. Global Influenza Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Influenza Drugs Price by Application (2019-2030) & (USD/MT)
Figure 27. North America Influenza Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Influenza Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Influenza Drugs Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Influenza Drugs Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Influenza Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Influenza Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Influenza Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Influenza Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Influenza Drugs Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Influenza Drugs Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Influenza Drugs Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Influenza Drugs Sales Volume (%), (2019-2030)
Figure 39. United States Influenza Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Influenza Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Influenza Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Influenza Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Influenza Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Influenza Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. China Influenza Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Influenza Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. China Influenza Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Influenza Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Influenza Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Influenza Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Influenza Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Influenza Drugs Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Influenza Drugs Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Influenza Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Influenza Drugs Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Influenza Drugs Sales Value by Application (%), 2023 VS 2030
Figure 57. India Influenza Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Influenza Drugs Sales Value by Type (%), 2023 VS 2030
Figure 59. India Influenza Drugs Sales Value by Application (%), 2023 VS 2030
Figure 60. Influenza Drugs Industrial Chain
Figure 61. Influenza Drugs Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
